BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37226315)

  • 1. Liver cirrhosis following oxaliplatin-based adjuvant chemotherapy for rectal cancer.
    Huang C; Chen J; Situ Y
    J Oncol Pharm Pract; 2023 Sep; 29(6):1520-1524. PubMed ID: 37226315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of liver fibrosis with splenomegaly after oxaliplatin-based adjuvant chemotherapy for colon cancer.
    Kang GH; Moon HS; Lee ES; Kim SH; Sung JK; Lee BS; Jeong HY; Lee HY; Kang DY
    J Korean Med Sci; 2013 Dec; 28(12):1835-8. PubMed ID: 24339718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?
    Madbouly KM; Hussein AM; Zeid A
    Dis Colon Rectum; 2013 May; 56(5):577-85. PubMed ID: 23575396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin toxicity presenting as a liver nodule - case report.
    Alexandrino H; Oliveira D; Cipriano MA; Ferreira L; Tralhão JG; Castro E Sousa F
    BMC Cancer; 2015 Apr; 15():247. PubMed ID: 25886004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin-induced liver injury mimicking metastatic tumor on images: a case report.
    Uchino K; Fujisawa M; Watanabe T; Endo Y; Nobuhisa T; Matsumoto Y; Kai K; Sato S; Notohara K; Matsukawa A
    Jpn J Clin Oncol; 2013 Oct; 43(10):1034-8. PubMed ID: 23958518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin-Induced Sinusoidal Obstruction Syndrome Masquerading as Colorectal Liver Metastasis: A Case Report.
    Gupta V; Chopde A; Patkar S; Deodhar K; Goel M
    J Gastrointest Cancer; 2023 Jun; 54(2):682-686. PubMed ID: 35666356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal Cancer: A Post Hoc Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
    Diefenhardt M; Ludmir EB; Hofheinz RD; Ghadimi M; Minsky BD; Rödel C; Fokas E
    JAMA Oncol; 2020 Sep; 6(9):1416-1421. PubMed ID: 32644104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of portal hypertension after the treatment of oxaliplatin based adjuvant chemotherapy for rectal cancer].
    Heo J; Shin KY; Kwon YH; Park SY; Jung MK; Cho CM; Tak WY; Kweon YO
    Korean J Gastroenterol; 2011 Apr; 57(4):253-7. PubMed ID: 21519180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
    Petrelli F; Labianca R; Zaniboni A; Lonardi S; Galli F; Rulli E; Rosati G; Corallo S; Ronzoni M; Cardellino GG; Mattioli R; Mambrini A; Ciuffreda L; Banzi M; Pusceddu V; Maiello E; Zampino M; Zagonel V; Marchetti P; Corsi D; Rimassa L; Cinieri S; Sobrero A
    JAMA Oncol; 2020 Apr; 6(4):547-551. PubMed ID: 32053133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
    Rubbia-Brandt L; Audard V; Sartoretti P; Roth AD; Brezault C; Le Charpentier M; Dousset B; Morel P; Soubrane O; Chaussade S; Mentha G; Terris B
    Ann Oncol; 2004 Mar; 15(3):460-6. PubMed ID: 14998849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophagogastric varices were diagnosed in a non-cirrhotic liver case during long-term follow-up after oxaliplatin-based chemotherapy.
    Shigefuku R; Watanabe T; Mizukami T; Matsunaga K; Hattori N; Ehira T; Suzuki T; Nakano H; Sato Y; Matsuo Y; Nakahara K; Ikeda H; Matsumoto N; Tsuda T; Katayama M; Koizumi S; Okuse C; Suzuki M; Otsubo T; Nakajima TE; Yasuda H; Itoh F
    Clin J Gastroenterol; 2018 Dec; 11(6):487-492. PubMed ID: 29948819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of portal hypertension after 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) chemotherapy].
    Ogata H; Gushima T; Maruoka S; Takasaki S; Tanaka R; Matsuura T; Aishima S; Takahashi K
    Nihon Shokakibyo Gakkai Zasshi; 2013 Dec; 110(12):2119-26. PubMed ID: 24305101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome.
    Park S; Kim HY; Kim H; Park JH; Kim JH; Kim KH; Kim W; Choi IS; Jung YJ; Kim JS
    Medicine (Baltimore); 2016 Jan; 95(2):e2454. PubMed ID: 26765438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model.
    Robinson SM; Mann J; Vasilaki A; Mathers J; Burt AD; Oakley F; White SA; Mann DA
    J Hepatol; 2013 Aug; 59(2):318-26. PubMed ID: 23624001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer.
    Naiken SP; Toso C; Rubbia-Brandt L; Thomopoulos T; Roth A; Mentha G; Morel P; Gervaz P
    BMC Surg; 2014 Jan; 14():4. PubMed ID: 24438090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterioportal shunt incidental to treatment with oxaliplatin that mimics recurrent gastric cancer.
    Kim HB; Park SG
    World J Gastroenterol; 2017 Sep; 23(33):6187-6193. PubMed ID: 28970735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
    Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
    Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in Japan.
    Ohta R; Yamada T; Hara K; Iwai T; Tanakaya K; Ishibashi K; Yoshimatsu K; Kosugi C; Tsubaki M; Nakajima H; Oya M; Yoshida H; Koda K; Ishida H
    Int J Clin Oncol; 2020 Dec; 25(12):2075-2082. PubMed ID: 32785799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.